Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness

Conventional platelet transfusion may not be adequate to deal with platelet transfusion refractoriness (PTR), and therefore human leukocyte antigen (HLA) or human platelet antigen (HPA) matched and platelet crossmatch compatible units are recommended. However, in developing countries, finding a unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chellaiya, Gayathiri K., Nair, Chandran K., Raghavan, Vineetha, Pandian, R. Jesu, Vinod, Roshan, Murugesan, Mohandoss
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294443/
https://www.ncbi.nlm.nih.gov/pubmed/34349464
http://dx.doi.org/10.4103/ajts.AJTS_81_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294443/
https://www.ncbi.nlm.nih.gov/pubmed/34349464
http://dx.doi.org/10.4103/ajts.AJTS_81_19

Ejemplares similares